Quoted Micro 6 April 2026

AQUIS STOCK EXCHANGE In 2025, heart health products developer ProBiotix Health (PBX) increased revenues by 45% to £2.73m. The loss was reduced from £852,000 to £1.24m. Revenues continue to grow in the first quarter of the new financial year, and it has achieved profitability. Cash was £1.27m at the end of 2025. The order book […]

Andrew Hore Quoted Micro 28 October 2019

NEX EXCHANGE Ashley House (ASH) is selling its stake in the Morgan Ashley joint venture to its partner for £2m, with £500,000 deferred for 12-months. Delays in the financial closure of projects has led to a shortage of funds at Ashley House and this deal means it does not have to put any more cash […]

Spectra Systems – To Significantly Exceed Expectations

Spectra Systems SPSY has been notified by its authentication technology licensee that royalties in 2017 will reach a record level to the extent that profits for the year to 31st December will significantly exceed market expectations. For 2018 it is expected that royalties will continue to be higher than average. Bioventix BVXP is increasing its […]

BT Caught Out in Major Fraud.

BT Group BT.A has reluctantly apologised for cheating on its Openreach customers over a number of years. After a whopping £42m fine which has now been imposed by Ofcom, it did not have much choice but it still has the audacity to try and get away with calling them “mistakes”. Ofcom takes a slighty different […]

Small cap awards 2016

Company of the year Bioventix (BVXP)   Bioventix develops and supplies sheep monoclonal antibodies for clinical diagnostic applications. Bioventix originally joined ISDX (Plus-quoted) in 2010 at a share price of 198p and then moved to AIM in April 2014. The share price is more than five times the original flotation price in 2010. The antibodies […]